India to China: Roxithromycin Export Trade Route
India has recorded 26 verified shipments of Roxithromycin exported to China, representing a combined trade value of $43.0K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $1.7K USD. The leading Indian exporter is MARK INDIA FORMULATION, which accounts for 55% of total export value with 1 shipments worth $23.6K USD. On the buying side, DALIAN FAIRUS TRADING CO LTD is the largest importer in China with $23.6K USD in purchases. The top 3 suppliers — MARK INDIA FORMULATION, GRECIAN PRIVATE LIMITED, ALLMPUS LABORATORIES PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to China Roxithromycin corridor is one of India's established pharmaceutical export routes, with 26 shipments documented worth a combined $43.0K USD. The route is dominated by MARK INDIA FORMULATION, which alone accounts for roughly 55% of all export value, reflecting the consolidated nature of India's roxithromycin manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $1.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with roxithromycin's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 28.5%, placing it at rank #14 among India's top roxithromycin export destinations globally.
On the import side, key buyers of Indian roxithromycin in China include DALIAN FAIRUS TRADING CO LTD, LIAONING SAILING INTERNATIONAL, SHENZHEN CHEMSTRONG SCIENTIFIC CO. DALIAN FAIRUS TRADING CO LTD is the single largest importer with 1 shipments valued at $23.6K USD.
Route Characteristics
- Average transit20 days
- Peak seasonQ4
- Primary modeSea freight
- Top portBombay Air
Market Position
- Global rank#14
- Annual growth+28.5%
- Demand growth+23.9%
- Regulatory ease79/100
Top 10 Indian Roxithromycin Exporters to China
Showing top 10 of 3 Indian suppliers exporting Roxithromycin to China, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MARK INDIA FORMULATION Avg $23.6K per shipment | 1 | $23.6K | 54.9% |
| 2 | GRECIAN PRIVATE LIMITED Avg $15.5K per shipment | 1 | $15.5K | 36.0% |
| 3 | ALLMPUS LABORATORIES PRIVATE LIMITED Avg $162 per shipment | 24 | $3.9K | 9.1% |
This table shows the top 10 of 3 Indian companies exporting roxithromycin to China, ranked by total trade value. The listed exporters are: MARK INDIA FORMULATION, GRECIAN PRIVATE LIMITED, ALLMPUS LABORATORIES PRIVATE LIMITED. MARK INDIA FORMULATION is the dominant supplier with 1 shipments worth $23.6K USD, giving it a 55% market share.
Top 10 Roxithromycin Importers in China
Showing top 10 of 3 known buyers in China receiving Roxithromycin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian roxithromycin in China include DALIAN FAIRUS TRADING CO LTD, LIAONING SAILING INTERNATIONAL, SHENZHEN CHEMSTRONG SCIENTIFIC CO. The largest importer is DALIAN FAIRUS TRADING CO LTD, accounting for $23.6K USD across 1 shipments — representing 55% of all roxithromycin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DALIAN FAIRUS TRADING CO LTD | 1 | $23.6K | 54.9% |
| 2 | LIAONING SAILING INTERNATIONAL | 1 | $15.5K | 36.0% |
| 3 | SHENZHEN CHEMSTRONG SCIENTIFIC CO | 24 | $3.9K | 9.1% |
Top 10 Roxithromycin Formulations Imported by China
Showing top 10 of 6 product formulations shipped on the India to China Roxithromycin route, ranked by trade value
China imports a wide range of roxithromycin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMACEUTICALS P P MEDICAMENT ROXON TABLETS 10 X 10 ROXITHROMYCIN TABLETS IP — accounts for $23.6K USD across 1 shipments. A total of 6 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICALS P P MEDICAMENT ROXON TABLETS 10 X 10 ROXITHROMYCIN TABLETS IP | 1 | $23.6K | 54.9% |
| 2 | P & P MEDICAMENT _ ROXGEE-150 TABLET ROXITHROMYCIN IP 150 MG COLOUR : TITANIUMDIOXIDE IP & BRILLIANT BLUE | 1 | $15.5K | 36.0% |
| 3 | ROXITHROMYCIN EP IMPURITY E 5MG*1VIAL,BATCH NO- ALL-ROX-2401 | 6 | $1.6K | 3.7% |
| 4 | ROXITHROMYCIN EP IMPURITY D 100MG*1VIAL,BATCH NO- ALL-ROX-2400 | 6 | $1.1K | 2.6% |
| 5 | ROXITHROMYCIN EP IMPURITY H 5MG*1VIAL,BATCH NO- ALL-ROX-2720 | 6 | $680 | 1.6% |
| 6 | ROXITHROMYCIN EP IMPURITY B 100MG*1VIAL,BATCH NO- ALL-ROX-2398 | 6 | $536 | 1.2% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 76%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
Bombay Air handles the highest volume with 24 shipments. Transit time averages 20 days by sea.
Market Dynamics
India's roxithromycin exports to China are driven primarily by a handful of large-scale manufacturers. MARK INDIA FORMULATION with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in China benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MARK INDIA FORMULATION, GRECIAN PRIVATE LIMITED, ALLMPUS LABORATORIES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $1.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as p & p medicament _ roxgee-150 tablet roxithromycin ip 150 mg colour : titaniumdioxide ip & brilliant blue and roxithromycin ep impurity e 5mg*1vial,batch no- all-rox-2401, suggesting that buyers in China tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, DALIAN FAIRUS TRADING CO LTD is the largest importer with 1 shipments worth $23.6K USD — representing 55% of all roxithromycin imports from India on this route.
Route Statistics
- Trade Volume
- $43.0K
- Avg. Shipment
- $1.7K
- Suppliers
- 3
- Buyers
- 3
- Transit (Sea)
- ~20 days
- Annual Growth
- +28.5%
Related Analysis
Other Roxithromycin Routes
Unlock the Full India to China Roxithromycin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 26 shipments on this route.
Frequently Asked Questions — India to China Roxithromycin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Roxithromycin to China?
The leading Indian exporters of Roxithromycin to China are MARK INDIA FORMULATION, GRECIAN PRIVATE LIMITED, ALLMPUS LABORATORIES PRIVATE LIMITED. MARK INDIA FORMULATION holds the largest market share at approximately 55% of total trade value on this route.
Q What is the total value of Roxithromycin exports from India to China?
India exports Roxithromycin to China worth approximately $43.0K USD across 26 recorded shipments. The average value per shipment is $1.7K USD.
Q Which ports does India use to ship Roxithromycin to China?
The most active port of origin is Bombay Air with 24 shipments. Indian exporters primarily use sea freight for this route, with 76% of shipments going by sea and 23% by air.
Q How long does shipping take from India to China for Roxithromycin?
The average transit time for Roxithromycin shipments from India to China is approximately 20 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to China Roxithromycin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 28.5% with demand growth tracking at 23.9%. The route is ranked #14 among India's top Roxithromycin export destinations globally.
Q How many suppliers are active on the India to China Roxithromycin route?
There are currently 3 active Indian suppliers exporting Roxithromycin to China. The market is moderately concentrated with MARK INDIA FORMULATION accounting for 55% of total shipment value.
Q Who are the main importers of Roxithromycin from India in China?
The leading importers of Indian Roxithromycin in China include DALIAN FAIRUS TRADING CO LTD, LIAONING SAILING INTERNATIONAL, SHENZHEN CHEMSTRONG SCIENTIFIC CO. DALIAN FAIRUS TRADING CO LTD is the largest buyer with 1 shipments worth $23.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to China export trade corridor identified from Indian Customs (DGFT) records for Roxithromycin.
- 2.Supplier/Buyer Matching: 3 Indian exporters and 3 importers in China matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 26 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
26 Verified Shipments
3 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists